These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19129523)

  • 21. Rofecoxib, Merck, and the FDA.
    Villalba L; Witter J
    N Engl J Med; 2004 Dec; 351(27):2875-8; author reply 2875-8. PubMed ID: 15625745
    [No Abstract]   [Full Text] [Related]  

  • 22. Pros and cons of off-label promotion investigations and prosecutions.
    Loucks MK
    Food Drug Law J; 2006; 61(3):577-83. PubMed ID: 16989041
    [No Abstract]   [Full Text] [Related]  

  • 23. Punishing health care fraud--is the GSK settlement sufficient?
    Outterson K
    N Engl J Med; 2012 Sep; 367(12):1082-5. PubMed ID: 22970920
    [No Abstract]   [Full Text] [Related]  

  • 24. The FDA at work: cutting-edge science promoting public health.
    Hilts PJ
    FDA Consum; 2006; 40(1):28-35, 39-41. PubMed ID: 16528824
    [No Abstract]   [Full Text] [Related]  

  • 25. "Calm, but still alert": Marketing Stelazine to disturbed America, 1958-1980.
    Hersch MH
    Pharm Hist; 2008; 50(4):140-8. PubMed ID: 19831020
    [No Abstract]   [Full Text] [Related]  

  • 26. FDA approved new drug bulletin. Gabapentin (neurontin).
    RN; 1994 Jul; 57(7):39-40. PubMed ID: 8047795
    [No Abstract]   [Full Text] [Related]  

  • 27. Safeguarding patient welfare: who's in charge?
    Henney JE
    Ann Intern Med; 2006 Aug; 145(4):305-7. PubMed ID: 16908923
    [No Abstract]   [Full Text] [Related]  

  • 28. Parke-Davis whistle-blower speaks at last.
    Larkin M
    Lancet Neurol; 2003 May; 2(5):264. PubMed ID: 12849165
    [No Abstract]   [Full Text] [Related]  

  • 29. A short history of pharmaceutical marketing.
    Ferner R
    BMJ; 2012 Nov; 345():e7801. PubMed ID: 23169805
    [No Abstract]   [Full Text] [Related]  

  • 30. The professional society circus.
    Kassirer JP
    J Public Health Policy; 2005 Dec; 26(4):400-3. PubMed ID: 16392739
    [No Abstract]   [Full Text] [Related]  

  • 31. Pfizer to pay $430 million over promoting drug to doctors.
    Harris G
    N Y Times Web; 2004 May; ():C6. PubMed ID: 15290803
    [No Abstract]   [Full Text] [Related]  

  • 32. The FDA and deference lost: a self-inflicted wound or the product of a wounded agency? A response to Professor O'Reilly.
    Vladeck DC
    Cornell Law Rev; 2008 Jul; 93(5):981-1002. PubMed ID: 18618967
    [No Abstract]   [Full Text] [Related]  

  • 33. Intended and unintended consequences of the gabapentin off-label marketing lawsuit among patients with bipolar disorder.
    Chace MJ; Zhang F; Fullerton CA; Huskamp HA; Gilden D; Soumerai SB
    J Clin Psychiatry; 2012 Nov; 73(11):1388-94. PubMed ID: 23146199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The First Amendment and FDA restrictions on off-label uses: the call for a new approach.
    Leghorn J; Brophy E; Rother P
    Food Drug Law J; 2008; 63(2):391-406. PubMed ID: 18561466
    [No Abstract]   [Full Text] [Related]  

  • 35. Patient package inserts: the proper prescription?
    Rowe HM
    Food Drug Law J; 1995; 50(1):95-124. PubMed ID: 10342988
    [No Abstract]   [Full Text] [Related]  

  • 36. Not as easy as it may appear: using radio frequency identification technology to fulfill the Prescription Drug Marketing Act's elusive pedigree requirement.
    Asamoah AK
    Food Drug Law J; 2006; 61(2):385-418. PubMed ID: 16903035
    [No Abstract]   [Full Text] [Related]  

  • 37. Rofecoxib, Merck, and the FDA.
    Kim PS; Reicin AS
    N Engl J Med; 2004 Dec; 351(27):2875-8; author reply 2875-8. PubMed ID: 15625342
    [No Abstract]   [Full Text] [Related]  

  • 38. Hidden in plain sight: the history of marketing and urology.
    Moran ME
    Urology; 2012 Dec; 80(6):1233-5. PubMed ID: 23040197
    [No Abstract]   [Full Text] [Related]  

  • 39. There really is no controversy.
    Samuels A
    Eur J Clin Nutr; 2009 Aug; 63(8):1044. PubMed ID: 18545263
    [No Abstract]   [Full Text] [Related]  

  • 40. Tabloid.
    Macfarlane R
    Lancet; 2009 Jan; 373(9659):205. PubMed ID: 19150694
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.